Physician profile
Alice Hilgart
NPI 1689326357
$2,154.51
in general payments reported to CMS, 2019-2025
30 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $645 · 2023: $744 · 2024: $377 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,304 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,303.97 |
| Travel and Lodging | $205.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Enterra Medical, INC. | $526.72 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $195.28 | 2023-2025 | Gattex |
| Janssen Biotech, INC. | $192.99 | 2022-2023 | Erleada |
| Merck Sharp & Dohme LLC | $146.05 | 2022-2023 | Keytruda, Lynparza |
| Kerecis Limited | $123.45 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Procept Biorobotics Corporation | $112.18 | 2023-2025 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $96.98 | 2022 | |
| Dendreon Pharmaceuticals LLC | $93.15 | 2022-2023 | Provenge |
| Vertex Pharmaceuticals Incorporated | $68.82 | 2024-2025 | |
| Heron Therapeutics, INC. | $67.39 | 2024 | Zynrelef |
| Astellas Pharma US INC | $58.06 | 2022 | |
| Myriad Genetic Laboratories, INC. | $52.09 | 2025 | Myrisk |
| Urovant Sciences INC | $46.57 | 2022 | |
| Alnylam Pharmaceuticals INC. | $44.78 | 2022-2023 | Givlaari |
| Ethicon US, LLC | $40.41 | 2024 | Harmonic |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $34.24 | 2024-2025 | Prevena |
| Novartis Pharmaceuticals Corporation | $23.16 | 2022 | |
| Hydrofera LLC | $22.25 | 2025 | Hydrofera Blue |
| Olympus America INC. | $21.81 | 2024 | Itind System |
| Innovation Technologies INC | $19.83 | 2025 | Irrisept |
| Smith+Nephew, INC. | $18.68 | 2025 | Collagenase Santyl |
| Convatec INC. | $18.60 | 2024 | |
| Tolmar, INC. | $18.30 | 2023 | |
| Urogen Pharma, INC. | $18.17 | 2023 | Jelmyto |
| Intuitive Surgical, INC. | $18.11 | 2023 | |
| Blue Earth Diagnostics | $17.99 | 2022 | |
| Mission Pharmacal Company | $15.41 | 2022 | |
| Hollister Incorporated | $15.12 | 2022 | |
| Hologic Sales and Service, LLC | $14.35 | 2025 | Magseed, Magtrace, Trunode |
| Coopersurgical, INC. | $13.57 | 2025 | Onetrac Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Hilgart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.